Dr. Haskell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Johnson and Johnson
920 Route 202 S
Raritan, NJ 08869Phone+1 908-927-3972
Education & Training
- NYU Grossman School of MedicineFellowship, Nephrology, 1980 - 1982
- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1977 - 1980
- New York Medical CollegeClass of 1977
Certifications & Licensure
- NY State Medical License 1978 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
- American Society of HypertensionHypertension
Publications & Presentations
PubMed
- 277 citationsRivaroxaban in Peripheral Artery Disease after Revascularization.Marc P Bonaca, Rupert M Bauersachs, Sonia S Anand, E Sebastian Debus, Mark R Nehler
The New England Journal of Medicine. 2020-05-21 - 5 citationsHealth-care Cost Impact of Continued Anticoagulation With Rivaroxaban vs Aspirin for Prevention of Recurrent Symptomatic VTE in the EINSTEIN-CHOICE Trial PopulationPhilip S. Wells, Martin H. Prins, Jan Beyer-Westendorf, Anthonie W. A. Lensing, Lloyd Haskell
Chest. 2018-12-01 - 2 citationsCost comparison of continued anticoagulation with rivaroxaban versus placebo based on the 1-year EINSTEIN-Extension trial efficacy and safety results.Philip S. Wells, Anthonie W. A. Lensing, Lloyd Haskell, Bennett Levitan, François Laliberté
Journal of Medical Economics. 2018-03-16
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: